Literature DB >> 18029173

Synthesis and evaluation of novel heterocyclic MMP inhibitors.

Ryuji Hayashi1, Xiaomin Jin, Gregory R Cook.   

Abstract

A variety of novel heterocyclic compounds were synthesized and evaluated for MMP inhibition. Broad spectrum inhibition of MMPs 1, 2, 9, and 12 was found with pyridinone-based compounds while N-heterocyclic triazoles and tetrazoles were largely ineffective. A highly selective tetrazole inhibitor for MMP-2 was discovered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18029173      PMCID: PMC2574968          DOI: 10.1016/j.bmcl.2007.10.020

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  30 in total

1.  Design and therapeutic application of matrix metalloproteinase inhibitors.

Authors:  M Whittaker; C D Floyd; P Brown; A J Gearing
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  Recent developments in the application of oxazoline-containing ligands in asymmetric catalysis.

Authors:  Helen A McManus; Patrick J Guiry
Journal:  Chem Rev       Date:  2004-09       Impact factor: 60.622

3.  Synthesis and evaluation of novel oxazoline MMP inhibitors.

Authors:  Gregory R Cook; Ethirajan Manivannan; Thane Underdahl; Viera Lukacova; Yufen Zhang; Stefan Balaz
Journal:  Bioorg Med Chem Lett       Date:  2004-10-04       Impact factor: 2.823

4.  Matrix metalloproteinase inhibitors: a structure-activity study.

Authors:  D E Levy; F Lapierre; W Liang; W Ye; C W Lange; X Li; D Grobelny; M Casabonne; D Tyrrell; K Holme; A Nadzan; R E Galardy
Journal:  J Med Chem       Date:  1998-01-15       Impact factor: 7.446

5.  Preparation of 5-substituted 1H-tetrazoles from nitriles in water.

Authors:  Z P Demko; K B Sharpless
Journal:  J Org Chem       Date:  2001-11-30       Impact factor: 4.354

6.  The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

Authors:  M D Sternlicht; A Lochter; C J Sympson; B Huey; J P Rougier; J W Gray; D Pinkel; M J Bissell; Z Werb
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

Review 7.  Activation mechanisms of matrix metalloproteinases.

Authors:  H Nagase
Journal:  Biol Chem       Date:  1997 Mar-Apr       Impact factor: 3.915

Review 8.  The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.

Authors:  M D Sternlicht; M J Bissell; Z Werb
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

Review 9.  Strategies for MMP inhibition in cancer: innovations for the post-trial era.

Authors:  Christopher Mark Overall; Carlos López-Otín
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

10.  New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.

Authors:  David T Puerta; Jana A Lewis; Seth M Cohen
Journal:  J Am Chem Soc       Date:  2004-07-14       Impact factor: 15.419

View more
  2 in total

1.  A macrophage cell model for selective metalloproteinase inhibitor design.

Authors:  Faith E Jacobsen; Matthew W Buczynski; Edward A Dennis; Seth M Cohen
Journal:  Chembiochem       Date:  2008-09-01       Impact factor: 3.164

2.  Synthesis and antibacterial activities of acylide derivatives bearing an aryl-tetrazolyl chain.

Authors:  Ling-Xing Shan; Ping-Hua Sun; Bao-Qin Guo; Xing-Jun Xu; Zhi-Qiang Li; Jia-Zhi Sun; Shu-Feng Zhou; Wei-Min Chen
Journal:  Drug Des Devel Ther       Date:  2014-09-24       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.